Incyte Correlations

INCY Stock  USD 101.08  1.01  1.01%   
The current 90-days correlation between Incyte and United Therapeutics is 0.19 (i.e., Average diversification). The correlation of Incyte is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Incyte Correlation With Market

Average diversification

The correlation between Incyte and DJI is 0.13 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Incyte and DJI in the same portfolio, assuming nothing else is changed.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Incyte. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
For more information on how to buy Incyte Stock please use our How to Invest in Incyte guide.

Moving against Incyte Stock

  0.52IMNN Imunon IncPairCorr
  0.52SGMO Sangamo TherapeuticsPairCorr
  0.48LYRA Lyra TherapeuticsPairCorr
  0.43CRBP Corbus PharmaceuticalsPairCorr
  0.39MBIO Mustang BioPairCorr
  0.38RNAZ Transcode TherapeuticsPairCorr
  0.38APLT Applied TherapeuticsPairCorr
  0.36BCT Briacell TherapeuticsPairCorr
  0.33IPHA Innate PharmaPairCorr
  0.46MMC MMC Old Symbol ChangePairCorr

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

ILMNGMAB
BIIBWAT
BIIBUTHR
BIIBGMAB
ILMNRPRX
THCWST
  

High negative correlations

ILMNZBH
ILMNWST
ZBHRPRX
ZBHGMAB
THCILMN
WSTRPRX

Risk-Adjusted Indicators

There is a big difference between Incyte Stock performing well and Incyte Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Incyte's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
UTHR  1.16  0.17  0.11 (2.13) 1.07 
 2.19 
 12.18 
GMAB  1.65  0.15  0.07  0.15  2.03 
 4.09 
 9.44 
RPRX  1.08  0.16  0.09  0.37  1.41 
 2.03 
 12.26 
DGX  0.99  0.01 (0.02)(0.39) 1.14 
 2.68 
 6.29 
ZBH  1.30 (0.27) 0.00 (0.42) 0.00 
 2.92 
 18.45 
WST  1.47 (0.38) 0.00 (0.58) 0.00 
 2.50 
 12.18 
WAT  1.12  0.05  0.03  0.11  1.05 
 3.35 
 8.38 
BIIB  1.40  0.26  0.13  0.46  1.67 
 3.11 
 9.61 
ILMN  2.14  0.66  0.35  3.27  1.36 
 4.19 
 28.04 
THC  1.46 (0.16) 0.00 (0.36) 0.00 
 3.14 
 14.80 

Incyte Corporate Management

Mr MDHead VPProfile
Sheila JDGeneral VPProfile
Alexis SmithVice RelationsProfile
Thomas TrayChief FinanceProfile
Pamela MurphyVice CommunicationsProfile
Patrick MayesVice ResearchProfile
Paula SwainExecutive ResourcesProfile